Alembic Pharmaceuticals Ltd (APLLTD):企業の財務・戦略的SWOT分析

◆英語タイトル:Alembic Pharmaceuticals Ltd (APLLTD) - Financial and Strategic SWOT Analysis Review
◆商品コード:GDPH51841FSA
◆発行会社(調査会社):GlobalData
◆発行日:2021年4月
◆ページ数:25
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:インド
◆産業分野:Pharmaceuticals and Healthcare
◆販売価格オプション(消費税別)
Site License(同一事業所内共有可)USD600 ⇒換算¥76,800見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD900 ⇒換算¥115,200見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Alembic Pharmaceuticals Ltd (APL) is a pharmaceutical company which manufactures and markets generic pharmaceutical products. The company’s active pharmaceutical ingredients include macrolides, NSAIDs, and other drugs. APL also offers branded formulations in the areas of antibiotics and antibacterial, cardiovascular, gynecological, cough and cold, gastroenterological, ophthalmological, anti-diabetic, orthopedic, urology, antihistamine, dermatological and herbal nutraceuticals. APL provides generic formulations such as anti-allergic, antimicrobials, anthelmintic, antiulcerants, nutritional and vitamin preparations, and others speciality products. The company has its research centres and manufacturing facilities in Vadodara, Gujarat and Baddi. APL is headquartered in Vadodara, Gujarat, India.

Alembic Pharmaceuticals Ltd Key Recent Developments

Feb 08,2021: USFDA inspection at Alembic Pharmaceuticals new injectable facility (F-3) at Karkhadi
Jan 19,2021: L2 : Business News | Incuspaze Launches Largest Coworking Space in Vadodara in Association with …
Jul 27,2020: Alembic Pharma gets board approval to raise up to Rs 1,000 crore via QIP
Jun 19,2020: Alembic Pharmaceuticals receives Establishment Inspection Report (EIR) for its general oral solid formulation facility (F-1) at Panelav
May 06,2020: Alembic Pharmaceuticals announces its joint venture, Aleor Dermaceuticals received establishment inspection report (EIR) for its formulation facility at Karkhadi

This comprehensive SWOT profile of Alembic Pharmaceuticals Ltd provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of GlobalData’s ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, GlobalData’s highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of Alembic Pharmaceuticals Ltd including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including*,

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Note*: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include,

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

【レポートの目次】

Table of Contents

Section 1 – About the Company

Alembic Pharmaceuticals Ltd – Key Information
Alembic Pharmaceuticals Ltd – Overview
Alembic Pharmaceuticals Ltd – Key Employees
Alembic Pharmaceuticals Ltd – Key Employee Biographies
Alembic Pharmaceuticals Ltd – Key Operational Heads
Alembic Pharmaceuticals Ltd – Major Products and Services
Alembic Pharmaceuticals Ltd – History
Alembic Pharmaceuticals Ltd – Company Statement
Alembic Pharmaceuticals Ltd – Locations And Subsidiaries
Alembic Pharmaceuticals Ltd
Head Office
Other Locations & Subsidiaries

Section 2 – Company Analysis

Alembic Pharmaceuticals Ltd – Business Description
Alembic Pharmaceuticals Ltd – Corporate Strategy
Alembic Pharmaceuticals Ltd – SWOT Analysis
SWOT Analysis – Overview
Alembic Pharmaceuticals Ltd – Strengths
Alembic Pharmaceuticals Ltd – Weaknesses
Alembic Pharmaceuticals Ltd – Opportunities
Alembic Pharmaceuticals Ltd – Threats
Alembic Pharmaceuticals Ltd – Key Competitors

Section 3 – Company Financial Performance Charts

Alembic Pharmaceuticals Ltd – Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts

Section 4 – Appendix

Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

Note*: Some sections may be missing if data is unavailable for the company

List of Tables

Alembic Pharmaceuticals Ltd, Key Information
Alembic Pharmaceuticals Ltd, Key Ratios
Alembic Pharmaceuticals Ltd, Share Data
Alembic Pharmaceuticals Ltd, Major Products and Services
Alembic Pharmaceuticals Ltd, History
Alembic Pharmaceuticals Ltd, Key Employees
Alembic Pharmaceuticals Ltd, Key Employee Biographies
Alembic Pharmaceuticals Ltd, Key Operational Heads
Alembic Pharmaceuticals Ltd, Other Locations
Alembic Pharmaceuticals Ltd, Subsidiaries
Alembic Pharmaceuticals Ltd, Key Competitors
Alembic Pharmaceuticals Ltd, SWOT Analysis
Alembic Pharmaceuticals Ltd, Ratios based on current share price
Alembic Pharmaceuticals Ltd, Annual Ratios
Alembic Pharmaceuticals Ltd, Interim Ratios
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

★海外企業調査レポート[Alembic Pharmaceuticals Ltd (APLLTD):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Chevron Nigeria Ltd:石油・ガス:M&Aディール及び事業提携情報
    Summary Chevron Nigeria Ltd (Chevron Nigeria) a subsidiary of Chevron Corporation is an oil and gas company that offers exploration, production and transportation of crude oil and natural gas. The company distributes products such as additives, jet fuels, base oil, chemical, fuel, lubricant, marine …
  • SBA Communications Corp (SBAC):企業の財務・戦略的SWOT分析
    Summary SBA Communications Corp (SBA) operates as a wireless communication infrastructure company . The company offers site leasing and site development services. It provides infrastructure solution such as towers, distributed antenna systems (DAS), buildings, rooftops and small cells. The company p …
  • Eesti Energia AS:企業の戦略・SWOT・財務分析
    Eesti Energia AS - Strategy, SWOT and Corporate Finance Report Summary Eesti Energia AS - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Meyer Burger Technology AG (MBTN):電力:M&Aディール及び事業提携情報
    Summary Meyer Burger Technology AG (Meyer Burger) is a technology company that specializes in systems and processes based on semiconductor technologies. It provides technology, systems, machinery and processes for cutting and handling crystalline and other high-grade materials. It supplies ultra-thi …
  • Dynegy Inc:企業の発電所・SWOT分析2018
    Dynegy Inc - Power Plants and SWOT Analysis, 2018 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key employees (executi …
  • Kotra Industries Berhad (KOTRA):企業の財務・戦略的SWOT分析
    Kotra Industries Berhad (KOTRA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weak …
  • TripAdvisor Inc:企業の戦略・SWOT・財務分析
    TripAdvisor Inc - Strategy, SWOT and Corporate Finance Report Summary TripAdvisor Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Glacier Media Inc. (GVC):企業の財務・戦略的SWOT分析
    Glacier Media Inc. (GVC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Hepion Pharmaceuticals Inc (HEPA):企業の財務・戦略的SWOT分析
    Summary Hepion Pharmaceuticals Inc (Hepion) formerly known as ContraVir Pharmaceuticals Inc, is a biopharmaceutical company that offers development and commercialization of targeted antiviral therapies. The company provides pipeline product such as TXL, potent prodrug of antiviral tenofovir and CRV4 …
  • Bioaster:製薬・医療:M&Aディール及び事業提携情報
    Summary Bioaster is a technology research institute that develops technologies and conducts research on infectious diseases and microbiology. The institute offers services in the therapeutic areas of respiratory diseases, diarrhea, AIDS and tuberculosis. It carries out technological research program …
  • Oando Plc (OANDO):企業の財務・戦略的SWOT分析
    Oando Plc (OANDO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Suncor Energy Inc (SU):石油・ガス:M&Aディール及び事業提携情報
    Summary Suncor Energy Inc (Suncor) is an integrated energy company that mainly focuses on the development of Athabasca oil sands. It carries out development and up gradation of oil sands; offshore and onshore oil and gas production; refining of crude oil and marketing of petroleum and petrochemical …
  • Goodrich Petroleum Corp (GDP):企業の財務・戦略的SWOT分析
    Goodrich Petroleum Corp (GDP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • DaChan Food (Asia) Limited:企業の戦略・SWOT・財務情報
    DaChan Food (Asia) Limited - Strategy, SWOT and Corporate Finance Report Summary DaChan Food (Asia) Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Corgenix Medical Corp:医療機器:M&Aディール及び事業提携情報
    Summary Corgenix Medical Corp (Corgenix), a subsidiary of Orgentec Diagnostika GmbH is a medical device company that offers medical diagnostic solutions. The company offers vascular disease products, infectious disease products, non-invasive liver biomarkers, and instrumentation. It offers an instru …
  • Fazoli’s System Management, LLC:企業の戦略・SWOT・財務情報
    Fazoli’s System Management, LLC - Strategy, SWOT and Corporate Finance Report Summary Fazoli’s System Management, LLC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • MyCartis NV-医療機器分野:企業M&A・提携分析
    Summary MyCartis NV (MyCartis), formerly Pronota NV is a biomarker analysis solution provider. The company develops multiplexed biomarker solutions through evalution and bio assays technology. It uses technologies such as barcoded microparticles, microfluidic assay cartridges and evalution instrumen …
  • Beckman Coulter Inc:企業の戦略的SWOT分析
    Beckman Coulter Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and se …
  • Vivartia Holdings SA.:企業の戦略的SWOT分析
    Vivartia Holdings SA. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • BJ’s Wholesale Club Inc:企業の戦略・SWOT・財務分析
    BJ's Wholesale Club Inc - Strategy, SWOT and Corporate Finance Report Summary BJ's Wholesale Club Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆